KR940021082A - Biotissue Integrity Formation Composition - Google Patents

Biotissue Integrity Formation Composition Download PDF

Info

Publication number
KR940021082A
KR940021082A KR1019930005122A KR930005122A KR940021082A KR 940021082 A KR940021082 A KR 940021082A KR 1019930005122 A KR1019930005122 A KR 1019930005122A KR 930005122 A KR930005122 A KR 930005122A KR 940021082 A KR940021082 A KR 940021082A
Authority
KR
South Korea
Prior art keywords
biotissue
tissue
biological tissue
composition
formation composition
Prior art date
Application number
KR1019930005122A
Other languages
Korean (ko)
Inventor
류형수
임혜정
Original Assignee
류형수
임혜정
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 류형수, 임혜정 filed Critical 류형수
Priority to KR1019930005122A priority Critical patent/KR940021082A/en
Publication of KR940021082A publication Critical patent/KR940021082A/en

Links

Abstract

본 발명은 생체조직보전재생조성물에 관한 것으로, 약용성분의 유효성분을 경피적으로 인체에 침투 흡수시키기 위한 새로운 조성물 및 드럭델 리버리 시스템(drug delivery system : D.D.S.)을 제공하는데 목적이 있으며, 특히 콜라겐, 요소 등의 폴리펩티드 및 키토산등을 함유하는 크림상 조성물에 아스코르빈산등의 필요한 기능성 성분을 배합한 것을 사용하므로써 본래의 생체조직과 일체화된 인공적인 생체조직을 형성하여 재생시켜 주므로써 인공생체조직으로도 이용 가능한 효과가 있다.The present invention relates to a tissue tissue regeneration composition, the object of the present invention is to provide a novel composition and drug delivery system (DDS) for percutaneously absorbing and absorbing the active ingredient of the medicinal ingredients, especially collagen By combining the necessary functional ingredients such as ascorbic acid with a creamy composition containing polypeptides such as urea, chitosan and the like, artificial biological tissue is formed by regenerating artificial biological tissue integrated with the original biological tissue. There is also an effect available.

Description

생체조직보전형조성물Biotissue Integrity Composition

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (2)

콜라겐, 요소등의 폴리펩티드, 키토산 및 기능성 성분으로 구성됨을 특징으로 하는 생체조직보전형성 조성물.A biotissue integrity-forming composition comprising collagen, polypeptides such as urea, chitosan, and functional ingredients. 제1항에 있어서, 기능성 성분으로는 아스코르빈산을 함유시키는 것을 특징으로 하는 생체조직보전형성 조성물.The composition of claim 1, wherein the functional component contains ascorbic acid. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019930005122A 1993-03-30 1993-03-30 Biotissue Integrity Formation Composition KR940021082A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930005122A KR940021082A (en) 1993-03-30 1993-03-30 Biotissue Integrity Formation Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930005122A KR940021082A (en) 1993-03-30 1993-03-30 Biotissue Integrity Formation Composition

Publications (1)

Publication Number Publication Date
KR940021082A true KR940021082A (en) 1994-10-17

Family

ID=66912392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930005122A KR940021082A (en) 1993-03-30 1993-03-30 Biotissue Integrity Formation Composition

Country Status (1)

Country Link
KR (1) KR940021082A (en)

Similar Documents

Publication Publication Date Title
DE69305328D1 (en) MICROCAPSULES WITH WALLS OF PRIMARY ALCOHOL FUNCTIONAL CONTAINING POLYSACCHARIDES, AND COMPOSITIONS THEREOF
KR890000101A (en) How to improve the treatment of banwol tissue and therapeutic drugs
EP0386960A3 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
KR900004325A (en) Nucleated granules and preparation method thereof
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
ES2140415T3 (en) PREPARATION OF MICROPARTICLES.
CA2258920A1 (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
KR920019342A (en) Bone Disease Treatment
PT89534A (en) PROCESS FOR THE PREPARATION OF ANTICOAGULANT PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE INGREDIENT PROTEIN C OR PROTEIN C ACTIVATED COMBINED WITH HEPARIN
MX9102353A (en) N, O-SULPHATES OF HEPAROSANES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINED IN THEM.
ATE173578T1 (en) IMPLANTABLE MOLDED BODY FOR ADMINISTRATION OF ACTIVE INGREDIENTS TO PLANTS
MXPA97007996A (en) Preparation for the transport of an active substance across barriers.
ATE98868T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING DEPOLYMERIZED NUCLEIC ACIDS FOR TOPICAL COSMETIC APPLICATION.
KR970032795A (en) Cosmetic and skin care compositions containing an effective amount of uric acid and uric acid degrading enzymes
KR910005876A (en) Minimal pharmaceutical compositions for the treatment of capillary weakness
KR950032272A (en) L-lysyl-glysil-L-histidine and therapeutic agent for wound fusion containing the same
KR880007068A (en) Use of 13-cis retinoic acid
KR940021082A (en) Biotissue Integrity Formation Composition
ATE95421T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PIROXICAM FOR TOPICAL USE.
KR930019224A (en) Abortion Hazard Remedy
KR890009395A (en) Inhalants
KR930003922A (en) Enzyme-containing herbal medicines
ES2134941T3 (en) LACTULOSE PILLS.
IT8521528A0 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8PHENYL-10 ANTRONE-9 AS THE ACTIVE INGREDIENT, AND PROCEDURE FOR PREPARATION OF THE ACTIVE INGREDIENT.
KR927002996A (en) Hair growth promoting composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application